# clm_8F4CF168CDB2

subject: AbbVie (/record/abbvie.md)  
predicate: cash_and_equivalents  
value: 13,287,000,000 United States dollar  
valid_from: 2023-09-30  
valid_to: 2023-12-31  
published: 2023-11-06  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_D3C029303D23  
last_updated: 2026-11-08  
cite: AsOf. "AbbVie cash and equivalents: 13,287,000,000 United States dollar", as of 2023-09-30 (until 2023-12-31). Claim clm_8F4CF168CDB2, https://asof.is/claim/clm_8F4CF168CDB2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000045/0001551152-23-000045-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2023, filed 2023-11-06  

## Sources

- https://www.sec.gov/Archives/edgar/data/1551152/000155115223000045/0001551152-23-000045-index.htm (primary, SEC EDGAR 10-Q Q3 FY2023, published 2023-11-06)

## Supersedes

- [AbbVie](/record/abbvie.md) | cash_and_equivalents | 8,759,000,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_8F4CF168CDB2](/claim/clm_8F4CF168CDB2.md) | [clm_F77382A19536](/claim/clm_F77382A19536.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.